Abstract
Abstract
Background
Changes that occur during pregnancy and after that during breastfeeding induce some symptoms similar to metabolic syndrome (MetS) risk factors. This study aims to determine the relationship between pregnancy, as well as the duration of breastfeeding and MetS controlling the effect of other risk factors like hypertension, glucose intolerance, triglyceride, central obesity, and reduction of high-density lipoprotein in women of Fasa Persian Cohort Study.
Materials and methods
In this cross-sectional study, 5015 women aged 35–70 years were investigated in the Sheshdeh region from 2016 to 2021, and the information related to the disease symptoms was collected through questionnaires, examinations, and laboratory tests. MetS was calculated based on two guidelines according to adult treatment panel III (ATP III) and international diabetes federation (IDF) methods. For reporting the data, the odds ratio with its 95% confidence interval was used. In order to eliminate the effect of confounders, logistic regression was used.
Results
Prevalence of MetS showed a descending trend in women with up to two pregnancies and it reached 22.6% and 22.4% using ATPIII and IDF methods respectively, while with an increase in the number of pregnancies of more than two, MetS prevalence was ascending. The prevalence of MetS did not have any specific trend across various breastfeeding duration groups. Multivariate analysis approved that the odds ratio of developing MetS in comparison with women who had two pregnancies was significantly increasing trend when the pregnancy counts increased.
Conclusion
The chance of developing MetS based on both IDF and ATP III methods after adjustment for confounding effects would grow with an increase in the number of pregnancies to more than two and breast-feeding of more than seven years. It is recommended that women with more than two pregnancies or the long duration of breast-feeding women undergo a specialized examination to investigate and control MetS problems so that future diseases could be prevented.
Funder
Fasa University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference91 articles.
1. Alizadeh Z, Azadbakht L. Review of epidemiology of metabolic syndrome in iran. Iran J Diabetes Metabolism. 2017;15(3):143–57.
2. Neufcourt L, Assmann K, Fezeu L, Touvier M, Graffouillère L, Shivappa N, et al. Prospective association between the dietary inflammatory index and metabolic syndrome: findings from the SU. VI. MAX study. Nutr Metabolism Cardiovasc Dis. 2015;25(11):988–96.
3. Osati S, Homayounfar R, Hajifaraji M. Metabolic effects of vitamin D supplementation in vitamin D deficient patients (a double-blind clinical trial). Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016;10(2):7–S10.
4. Amiri A, Hakimi A. The study of prevalence of metabolic syndrome among nurses of Shahid Mohammadi Hospital of Bandar Abbas city, Iran. J Clin Nurs Midwifery. 2017;6.
5. Dalvand S, Bakhshi E, Zarei M, Taheri Asl M, Ghanei Gheshlagh R. Prevalence of metabolic syndrome in Iran: a systematic review and meta-analysis. Medical-Surgical Nurs J. 2017;5(4).